Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus

JAMA Dermatol. 2021 Jul 1;157(7):880-882. doi: 10.1001/jamadermatol.2021.1198.

Authors

Daniel R Mazori¹, Michelle S Min¹, Bina Kassamali¹, Lars Brichta², Joseph F Merola^{1

3}, Ruth Ann Vleugels¹, Avery H LaChance¹

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Chemistry Rx Compounding and Specialty Pharmacy, Folcroft, Pennsylvania.
³ Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 34076672
DOI: 10.1001/jamadermatol.2021.1198

No abstract available

MeSH terms

Humans
Lupus Erythematosus, Discoid* / diagnosis
Lupus Erythematosus, Discoid* / drug therapy
Ointments
Piperidines* / therapeutic use
Pyrimidines / adverse effects

Substances

Ointments
Piperidines
Pyrimidines
tofacitinib